Jheng-Yen Wu

65PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsRespiratory diseasesMajor global burdens of diseaseMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Aug 17, 2026
Risk of Bone Mineral Density Loss Associated with GLP-1 Receptor Agonists in Overweight COPD Populations [Response to Letter].

|Jul 17, 2026
Comparative Cardiovascular Outcomes of Tirzepatide and Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.

|Jul 10, 2026
Association Between Sacubitril/Valsartan Use and Risk of Major Adverse Cardiovascular Events in Patients With Durable Left Ventricular Assist Devices: A Multi-Institutional Real-World Cohort Study.

|Jul 08, 2026
Direct-Acting Antiviral Therapy and Long-Term Outcomes in Dialysis Patients With Hepatitis C: A Real-world Cohort Study.

|Jun 29, 2026
Clinical benefits of tirzepatide in patients with steatotic liver disease and cardiometabolic dysfunction.

|Jun 23, 2026
The association between sodium-glucose cotransporter 2 inhibitor and risk of pancreatic cancer among patients with type 2 diabetes mellitus: A real-world cohort study.

Pageof 11

Frequent Collaborators

27 joint publications

Chih-Cheng Lai

17 joint publications

Po-Yu Huang

17 joint publications

Ya-Wen Tsai

15 joint publications

Kuo-Chuan Hung